Back to search

France· FR:66502733

VEDROP 50 mg/ml, solution buvable

A tocofersolan product containing tocofersolan, registered in France by RECORDATI RARE DISEASES. The same ATC class is registered in 11 of our 19 countries.

ATC A11HA08

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVEDROP 50 mg/ml, solution buvableATCA11HA08REGISTER NO.FR:66502733PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Tocofersolan is registered in 11 of 19 countries.

Countries holding a registration under ATC A11HA08 (tocofersolan), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Tocofersolan · ATC A11HA08

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TOCOFERSOLAN
Manufacturer
RECORDATI RARE DISEASES
Country
France (FR)
ATC code
A11HA08
ATC class
Tocofersolan
Defined daily dose
0.2 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400939896908
    1 flacon(s) en verre polyéthylène haute densité (PEHD) de 20 ml avec seringue(s) pour administration orale de 1 ml
  • cip13
    3400939897097
    1 flacon(s) en verre polyéthylène haute densité (PEHD) de 60 ml avec seringue(s) pour administration orale de 2 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da09a094-bde1-4330-b871-74fb92413f50
GET /v1/drugs/da09a094-bde1-4330-b871-74fb92413f50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66502733",
  "date_amm": "2009-07-24",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/09/533",
  "substance": "TOCOFERSOLAN",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about tocofersolan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.